Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acadia Healthcare Company Inc (ACHC) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

Acadia Healthcare Company IncTrade
Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Acadia Healthcare Company Inc vs Recursion Pharmaceuticals Inc — how do they compare? Acadia Healthcare Company Inc trades at $31.35 (market cap $2.90B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Acadia Healthcare Company Inc is the larger of the two by market cap, and Acadia Healthcare Company Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

ACHCRXRX
Market Cap
$2.90B$1.81B
Sector
HealthHealth
52-Week High
$35.61$6.79
52-Week Low
$11.68$2.84
Enterprise Value
$5.29B$1.33B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Acadia Healthcare Company Inc

Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.

Read more on ACHC

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX